Peptide Hormones as Tumor Markers in Neuroendocrine Gastrointestinal Tumors
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Since the development of the radioimmunoassay, the determination of serum or plasma levels of peptides has improved the diagnostic possibilities in neuroendocrine gastrointestinal and pancreatic tumors. Once the diagnosis of a carcinoid or an endocrine pancreatic tumor has been established the analyses of various peptides can help to characterize the tumor. Up till now there has been no 'screening' marker for the early detection of these tumors. The development of radioimmunoassay for analyses of chromogranins in plasma might imply such possibilities. In the management of the patients it is also important to have tumor markers that can give prognostic information. Recent findings might indicate that CA-50 could be an indicator of malignant disease and possibly also correlate with survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Cited by
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Self-citationPape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Tumor Markers in Neuroendocrine Tumors
Eriksson, B., Öberg, K., & Stridsberg, M. (2000) · Digestion · doi:10.1159/000051853 · Cited by 299
Self-citationBajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E., & Bombardieri, E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990901)86:5<858::aid-cncr23>3.0.co;2-8 · Cited by 289
Metadata
- Authors
- Eriksson, B., & Oberg, K.
- Venue
- Acta Oncologica
- Published
- 1991-01
- Volume
- 30
- Issue
- 4
- Pages
- 477-483
- ISSN
- 0284-186X (ISSN-L)
- 1651-226X
- OpenAlex
- W2003445752
- Cited by
- 67
- References
- 1
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peptide Hormones as Tumor Markers in Neuroendocrine Gastrointestinal Tumors. https://app.cochat.ai/papers/10.3109/02841869109092404
- The paper
- Eriksson, B., & Oberg, K. (1991). Peptide Hormones as Tumor Markers in Neuroendocrine Gastrointestinal Tumors. Acta Oncologica. https://doi.org/10.3109/02841869109092404
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.